-
Loading metrics
Correction: Challenges in Developing a Validated Biomarker for Angiogenesis Inhibitors: The Motesanib Experience
- The PLOS ONE Staff
![PLOS](/resource/img/logo-plos.png)
x
- Published: March 26, 2015
- https://doi.org/10.1371/journal.pone.0121162
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Loading metrics